NCT00562133View on ClinicalTrials.gov

Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

March 31, 2007

Conditions
Diabetes Mellitus
Interventions
DRUG

Insulin Glulisine

100 IU/ml, 0.10 U/kg immediately before ingestion of a standardised liquid meal

DRUG

Insulin

100 IU/ml, 0.10 U/kg 15 Minutes before ingestion of a standardised liquid meal

Trial Locations (1)

55116

Ikfe, Mainz

All Listed Sponsors
lead

IKFE Institute for Clinical Research and Development

OTHER

NCT00562133 - Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes | Biotech Hunter | Biotech Hunter